Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Alexion Pharmaceuticals (NASDAQ: ALXN) and Vertex Pharmaceuticals (NASDAQ: VRTX) rank as two of the most successful biotechs focused on rare diseases on the planet. The stock performances for both companies underscore that success: Both Alexion's and Vertex's share prices have more than quintupled over the last 10 years.
But which of these rare-disease winners is the better pick for long-term investors now? Here's how Alexion and Vertex compare in three key areas.
Image source: Getty Images.
Source Fool.com